We read with great interest the recent proposals for an update on the histologic classification of mesothelioma and salute the authors for such a detailed piece of work. 1 As health care practitioners working in the Northeast England with one of the United Kingdom's highest rates of pleural mesothelioma, 2 we welcome such proposals. Nevertheless, we must disagree with one of the points in Table 3, cytology point L, that the deciduoid variant of pleural mesothelioma has no prognostic significance. We agree that deciduoid cytology needs to be distinguished from carcinomas, but we have recently come across a case of deciduoid pleural mesothelioma which was associated with a very poor response to chemotherapy and a very limited life span in a patient with, initially, excellent performance status. 3 Our literature review revealed that the deciduoid variant is associated with a very poor prognosis, with an approximate 1-year mortality of 68%. Nevertheless, we are well aware that there are no large-scale survival studies for deciduoid pleural mesothelioma because it is a rare entity. Perhaps a word of caution in the proposals toward that should be inserted?